Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower potassium versus standard potassium-containing maintenance fluids in hospitalized children
IRCT20240513061780N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of potassium chloride, dextrose and sodium chloride in hypokalemia (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Serum potassium level, Blood urea nitrogen and 3 more. Started May 2024; status: completed.
02
Drugs
potassium chloridedextrosesodium chloride
03
Conditions
hypokalemia
Beyond the preview
Go deeper on IRCT20240513061780N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240513061780N1.